We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$999B
AUM Growth
+$24.7B
Cap. Flow
-$14B
Cap. Flow %
-1.41%
Top 10 Hldgs %
24.27%
Holding
2,908
New
248
Increased
1,171
Reduced
1,334
Closed
66

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$3.3B
2
LLY icon
Eli Lilly
LLY
+$2.75B
3
AZN icon
AstraZeneca
AZN
+$1.98B
4
CPNG icon
Coupang
CPNG
+$1.54B
5
FTNT icon
Fortinet
FTNT
+$1.48B

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$2.34B
2
MS icon
Morgan Stanley
MS
+$2.26B
3
ABNB icon
Airbnb
ABNB
+$2.04B
4
QCOM icon
Qualcomm
QCOM
+$1.95B
5
NVDA icon
NVIDIA
NVDA
+$1.81B

Sector Composition

Rank Sector Weight
1 Technology 23.35%
2 Healthcare 16.19%
3 Consumer Discretionary 15.55%
4 Financials 12.84%
5 Communication Services 12.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAACW
2776
DELISTED
Health Assurance Acquisition Corp. Warrants
HAACW
$91K ﹤0.01%
+35,000
New +$119K
HDSN
2777
Hudson Technologies
HDSN
$236M
$89K ﹤0.01%
+55,160
New +$80.1K
SIGA icon
2778
SIGA Technologies
SIGA
$206M
$88K ﹤0.01%
+13,589
New +$92.1K
OCGN icon
2779
Ocugen
OCGN
$475M
$84K ﹤0.01%
+12,300
New +$81.8K
VTGN icon
2780
VistaGen Therapeutics
VTGN
$11.6M
$84K ﹤0.01%
+1,317
New +$87.9K
HROW icon
2781
Harrow
HROW
$1.48B
$83K ﹤0.01%
+12,326
New +$101K
QXO
2782
QXO Inc
QXO
$16.2B
$83K ﹤0.01%
+1,363
New +$61K
TELL
2783
DELISTED
Tellurian Inc.
TELL
$81K ﹤0.01%
34,582
+23,275
+206% +$63.5K
EGY icon
2784
Vaalco Energy
EGY
$602M
$80K ﹤0.01%
+35,900
New +$94.6K
GNSS icon
2785
Genasys
GNSS
$77.4M
$77K ﹤0.01%
+11,565
New +$84.2K
IGC icon
2786
IGC Pharma
IGC
$29.8M
$77K ﹤0.01%
+43,000
New +$78.1K
DWSN icon
2787
Dawson Geophysical
DWSN
$136M
$76K ﹤0.01%
30,980
BOAC.WS
2788
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$74K ﹤0.01%
+49,000
New +$106K
MLSS icon
2789
Milestone Scientific
MLSS
$46.8M
$72K ﹤0.01%
+20,137
New +$69K
ASAP
2790
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$71K ﹤0.01%
1,219
-935
-43% -$62K
EMAN
2791
DELISTED
eMagin Corporation
EMAN
$69K ﹤0.01%
+18,500
New +$62.3K
OIS icon
2792
Oil States International
OIS
$536M
$68K ﹤0.01%
11,353
-4,829
-30% -$32.9K
CATX icon
2793
Perspective Therapeutics
CATX
$372M
$67K ﹤0.01%
+6,150
New +$92.9K
CNVS icon
2794
Cineverse
CNVS
$68.9M
$67K ﹤0.01%
+2,005
New +$56.1K
QUAD icon
2795
Quad
QUAD
$507M
$66K ﹤0.01%
18,838
-11,583
-38% -$55.2K
XTNT icon
2796
Xtant Medical Holdings
XTNT
$43.5M
$66K ﹤0.01%
+27,900
New +$59.6K
ALR
2797
DELISTED
AlerisLife Inc
ALR
$66K ﹤0.01%
+10,774
New +$77.8K
MACK
2798
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$66K ﹤0.01%
+10,500
New +$75K
EXTN
2799
DELISTED
Exterran Corporation
EXTN
$63K ﹤0.01%
+18,746
New +$86.9K
SYNC
2800
DELISTED
Synacor, Inc.
SYNC
$61K ﹤0.01%
+27,800
New +$54.4K

Similar funds

T. Rowe Price Associates's Q1 2021 Portfolio in Review

As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
  • T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
  • T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
  • T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
  • T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
  • T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
  • T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.

Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.